Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study
| Image |  |
|---|---|
| Description | scientific article published on 04 June 2017 |
| Author/s |
author: Peter Malfertheiner Masatoshi Kudo Markus Peck-Radosavljevic |
| Publication date | June 4, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |